-transparent.png){kind=logo}
The skin reactivity to 2, 4 dinitrochlorobenzene (DNCB) was evaluated in 94 healthy term neonates, aged 1-30 days and in 190 infants aged 2-9 months. For contact sensitization to DNCB an initial dose of 1 mg DNCB and a challenge one of 0.1 mg were used. Sensitization was induced in 6.7% of neonates in the first 15 days of life. This proportion rose to 25.7% by the end of the first month, to 63% in the third month and to 91% in the ninth month. It is concluded that DNCB test is a safe and simple screening test for evaluating cell-mediated immunity in the first months of life. It appears to have some advantages over the skin tests using specific antigens, as a positive result with DNCB can be obtained at an earlier age.
C Cassimos, and
F Kanakoudi-Tsakalidis, and
K Spyroglou, and
M Ladianos, and
R Tzaphi
February 1982,
Annals of allergy,
C Cassimos, and
F Kanakoudi-Tsakalidis, and
K Spyroglou, and
M Ladianos, and
R Tzaphi
January 1997,
Acta chirurgica Hungarica,
C Cassimos, and
F Kanakoudi-Tsakalidis, and
K Spyroglou, and
M Ladianos, and
R Tzaphi
January 1986,
Neoplasma,
C Cassimos, and
F Kanakoudi-Tsakalidis, and
K Spyroglou, and
M Ladianos, and
R Tzaphi
September 1972,
Pediatria polska,
C Cassimos, and
F Kanakoudi-Tsakalidis, and
K Spyroglou, and
M Ladianos, and
R Tzaphi
July 2011,
Immunobiology,
C Cassimos, and
F Kanakoudi-Tsakalidis, and
K Spyroglou, and
M Ladianos, and
R Tzaphi
January 1983,
Przeglad lekarski,
C Cassimos, and
F Kanakoudi-Tsakalidis, and
K Spyroglou, and
M Ladianos, and
R Tzaphi
January 1967,
The Journal of investigative dermatology,
C Cassimos, and
F Kanakoudi-Tsakalidis, and
K Spyroglou, and
M Ladianos, and
R Tzaphi
January 1979,
Vestnik dermatologii i venerologii,
C Cassimos, and
F Kanakoudi-Tsakalidis, and
K Spyroglou, and
M Ladianos, and
R Tzaphi
October 1978,
Wiadomosci lekarskie (Warsaw, Poland : 1960),
C Cassimos, and
F Kanakoudi-Tsakalidis, and
K Spyroglou, and
M Ladianos, and
R Tzaphi
January 1984,
Dermatologische Monatschrift,
